Search - tctmd.com

Displaying 161 - 180 of 182

Sort: Relevancy | Date

News Industry News

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

March 11, 2013

News Industry News

Abbott Initiates Clinical Trial of Absorb™ in the United States

January 07, 2013

Presentation TCT 2012

BVS Follow-up Using Multiple Imaging Modalities: Research Implications vs. Clinical Utility

Presenter: Yoshinobu Onuma

October 25, 2012

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

Can BVS Be Used in Complex Coronary Anatomy? A Series of Case Presentations

Presenter: Antonio Colombo

October 23, 2012

News Industry News

Abbott Announces International Launch of the Absorb™ Bioresorbable Vascular Scaffold

September 25, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

News Daily News

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

Jason Kahn

April 17, 2012

News Daily News

El Primer Stent Biodegradable Implantado resulta Seguro a los 10 Años

Jason Kahn

April 17, 2012

News Industry News

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

March 20, 2012

Presentation TCT 2012

Quantitative OCT Analysis of In-stent Neointimal Growth after Implantation of ABSORB™ BVS in a Diabetic Animal Model.

Presenter: Nienke van Ditzhuijzen, Oana Sorop, Mieke van den Heuvel, Jurgen M.R. Ligthart, Karen T. Witberg, Richard van Duin, Ilona Krabbendam-Peters, Douglas Follett, Nagarajan Ramesh, Richard Rapoza, Dirk J. Duncker, Evelyn Regar, Heleen M.M. van Beusekom, Hector M. Garcia-Garcia, Wim J. van der Giessen

January 03, 2012

News Industry News

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

December 31, 2011

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Conference News

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

November 08, 2011

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Industry News

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

September 08, 2011

News Industry News

First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical Trial

August 16, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Industry News

Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results

April 03, 2011

Advertisement

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

Abbott Initiates Clinical Trial of Absorb™ in the United States

BVS Follow-up Using Multiple Imaging Modalities: Research Implications vs. Clinical Utility

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Can BVS Be Used in Complex Coronary Anatomy? A Series of Case Presentations

Abbott Announces International Launch of the Absorb™ Bioresorbable Vascular Scaffold

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Strong Showing for Bioabsorbable-Scaffold DES

First Implanted Biodegradable Stent Shows Positive Safety at 10 Years

El Primer Stent Biodegradable Implantado resulta Seguro a los 10 Años

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

Quantitative OCT Analysis of In-stent Neointimal Growth after Implantation of ABSORB™ BVS in a Diabetic Animal Model.

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

Abbott to Present New Data for Key Vascular Products at TCT 2011

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical Trial

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content